Some gene therapies no longer require clinical trials, thanks to new FDA rule. Is this safe, and who will it help?
The FDA is launching a new framework to deliver tailor-made gene therapies to people with rare genetic disorders. Discussions about whom to treat and how to monitor patients are ongoing.
Original Source
Read the full article at Livescience →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.